ENHERTU ratings & reviews

Trastuzumab Deruxtecan
Company: Daiichi
Brand: ENHERTU
Drug class: Antineoplastic and Immunomodulating Agents
+6 more
Antineoplastic and Immunomodulating Agents, Antineoplastics, Antineoplastic Drug Conjugates, Antineoplastic Monoclonal Antibodies, Antineoplastic Monoclonal Antibodies Targeting Growth Factor Receptors and their Ligands, Antineoplastic Monoclonal Antibody-Drug Conjugates (ADCs), Antineoplastic Monoclonal Antibodies Targeting HER2/neu

Sermo AI Overview

  • Many physicians have noted mixed reviews about ENHERTU's efficacy and tolerability, highlighting a need for individualized treatment plans based on the specific cancer type and patient characteristics, as opinions differ significantly.
  • Patient adherence to ENHERTU varies across indications, with ratings ranging from 3.6 to 3.7, indicating that some patients may struggle to maintain consistent treatment, which could impact overall outcomes.
  • While ENHERTU has potential benefits, access and overall effectiveness vary significantly across regions and specialties, with specialists expressing concerns about its real-world application and variability in patient outcomes.
  • ENHERTU shows strong efficacy for treating HER2-positive solid tumors and non-small cell lung cancer, though gastroenterologists report limited benefit for gastric cancer. Mixed opinions exist on its tolerability and overall effectiveness across specialties.
Based on insights from Sermo’s triple verified physicians

Description

ENHERTU is formulated with the active ingredient fam-trastuzumab deruxtecan-nxki, a HER2-directed antibody and topoisomerase inhibitor conjugate. It acts as an antibody-drug conjugate, combining an anti-HER2 monoclonal antibody linked to a topoisomerase inhibitor, DXd. The drug is presented as a lyophilized powder, available in single-dose vials with 100 mg strength, reconstituted to a 20 mg/mL solution for intravenous infusion. Key inactive ingredients include L-histidine, L-histidine hydrochloride monohydrate, polysorbate 80, and sucrose.

Source: This information is sourced from FDA and powered by AI

Dosage & Administration

How should I use this medication?

This medication is injected into a vein. It is given by your care team in a hospital or clinic setting. A special MedGuide will be given to you before each treatment. Be sure to read this information carefully each time. Talk to your care team about the use of this medication in children. Special care may be needed.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once. NOTE: This medicine is only for you. Do not share this medicine with others.

What if I miss a dose?

It is important not to miss your dose. Call your care team if you are unable to keep an appointment.

Where should I keep my medication?

This medication is given in a hospital or clinic. It will not be stored at home.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.

Side Effects

What side effects may I notice from receiving this medication?

Side effects that you should report to your care team as soon as possible: -Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat -Dry cough, shortness of breath or trouble breathing -Infection—fever, chills, cough, sore throat, wounds that don't heal, pain or trouble when passing urine, general feeling of discomfort or being unwell -Heart failure—shortness of breath, swelling of the ankles, feet, or hands, sudden weight gain, unusual weakness or fatigue -Unusual bruising or bleeding Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome): -Constipation -Diarrhea -Hair loss -Muscle pain -Nausea -Vomiting

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings & Precautions

What should I tell my care team before I take this medication?

They need to know if you have any of these conditions: -Heart disease -Heart failure -Infection, especially a viral infection, such as chickenpox, cold sores, or herpes -Liver disease -Lung or breathing disease, such as asthma or COPD -An unusual or allergic reaction to fam-trastuzumab deruxtecan, other medications, foods, dyes, or preservatives -Pregnant or trying to get pregnant -Breast-feeding

What may interact with this medication?

Interactions are not expected.

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medication?

Visit your care team for regular checks on your progress. Tell your care team if your symptoms do not start to get better or if they get worse. This medication may increase your risk of getting an infection. Call your care team for advice if you get a fever, chills, sore throat, or other symptoms of a cold or flu. Do not treat yourself. Try to avoid being around people who are sick. Avoid taking medications that contain aspirin, acetaminophen, ibuprofen, naproxen, or ketoprofen unless instructed by your care team. These medications may hide a fever. Be careful brushing or flossing your teeth or using a toothpick because you may get an infection or bleed more easily. If you have any dental work done, tell your dentist you are receiving this medication. This medication may cause dry eyes and blurred vision. If you wear contact lenses, you may feel some discomfort. Lubricating eye drops may help. See your care team if the problem does not go away or is severe. Talk to your care team if you may be pregnant. Serious birth defects can occur if you take this medication during pregnancy and for 7 months after the last dose. If your partner can get pregnant, use a condom during sex while taking this medication and for 4 months after the last dose. Do not breastfeed while taking this medication and for 7 months after the last dose. This medication may cause infertility. Talk to your care team if you are concerned about your fertility.

What are the most serious risks of this medication?

If you can become pregnant, you will need a test to make sure you are not pregnant before starting this medication. You must use contraception while taking this medication. You may need to keep using contraception even after you stop taking the medication. This depends on the medication. It is important to talk to your care team about how long to use contraception. Call your care team right away if you think you may be pregnant, have unprotected sex, or if you think your contraception did not work. This medicine may cause serious, life threatening lung damage.

Source: This information is sourced from Elsevier Inc.

Disclaimer

The reviews, ratings, comments, and opinions expressed on this platform are solely those of the individual medical professionals who posted them and do not reflect the views or positions of Sermo, Inc. Sermo does not endorse, verify, or validate the content of individual reviews. The information provided is user-generated and reflects personal clinical experiences, which may not be complete, accurate, or applicable to your specific health needs. It is not intended as medical advice.

Prescription medications affect individuals differently, and what works for one person may not work for another. Always consult your doctor, pharmacist, or other qualified healthcare provider to ensure the information displayed applies to your personal circumstances. Only a licensed healthcare provider can advise you on what is safe and effective for you.

Keep all medications out of the reach of children, never share your medicine with others, and use each medication only as prescribed. Your reliance on any information provided on this platform is at your own risk.

Terms of use

  1. Sermo Drug Ratings, and all information provided on this website, may not be used in combination with any artificial intelligence tool (including to train an algorithm, test, process, analyze, generate output and/or develop any form of artificial intelligence tool). 

  2. Visitors to the online patient-facing website at Sermo.com (“Sermo Drug Ratings”) are Authorized Users of the website, which contains data owned by a third-party provider, Elsevier, Inc.  Accordingly, by visiting Sermo Drug Ratings, Authorized User acknowledges that the website includes Elsevier owned data that Sermo licenses pursuant to a separate usage and Data agreement (the “Agreements”).  Authorized User further acknowledges that Sermo is a third-party beneficiary of the Agreements and Authorized User’s use of the website hereby binds them to the terms of the Agreements; provided, however, that Elsevier shall have no obligations or liability to an Authorized User whatsoever pursuant to the terms of the Agreements.

Welcome to Sermo's Drug Ratings

Previously only for members, Sermo Drug Ratings are now openly available to all healthcare providers, patients, and industry professionals to support better healthcare decisions.

Clinical expertise
Insights based on real prescribing experience from triple-verified practicing physicians only
Detailed insights
Ratings on key attributes including efficacy, safety, tolerability, accessibility, and adherence
Unbiased reviews
Independent, physician-only reviews, free from pharmaceutical industry influence